Deprizine
NDC Package 70332-104-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Deprizine is a . Marketed by California Pharmaceuticals, Llc, this product is identified by NDC 70332-104.

Identification & Billing

NDC Package Code
70332-104-01
Package Description
1 KIT in 1 KIT * 6.4 g in 1 BOTTLE * 250 mL in 1 BOTTLE
Product Code
70332-104
11-Digit Billing Format
70332010401
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Deprizine
Dosage Form
-

Regulatory & Marketing

Labeler Name
California Pharmaceuticals, Llc
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-01-2016
End Marketing Date
01-05-2018
Listing Expiration
01-05-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70332-104-01 identifies a specific commercial package of 1 kit in 1 kit * 6.4 g in 1 bottle * 250 ml in 1 bottle of Deprizine, labeled by California Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by California Pharmaceuticals, Llc on January 01, 2016. The current certification is valid through January 05, 2018.

How is this California Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70332010401. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70332-104-01
11-Digit CMS (5-4-2)
70332-0104-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.